Search research articles
Contact Us
Filters
Showing results (21-30 of 47) with videos related to
Page
of 5
Sort By:
Cancers
|
May 5, 2021
The Impact of DNMT3A Status on NPM1 MRD Predictive Value and Survival in Elderly AML Patients Treated Intensively
Maël Heiblig, Nicolas Duployez, Alice Marceau, et al.
Haematologica
|
August 16, 2019
PIEZO1 activation delays erythroid differentiation of normal and hereditary xerocytosis-derived human progenitor cells
Alexis Caulier, Nicolas Jankovsky, Yohann Demont, et al.
Blood Advances
|
May 19, 2023
LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA study
Loïc Vasseur, Laurène Fenwarth, Jérôme Lambert, et al.
Blood Advances
|
April 8, 2025
Gut microbiota restoration with oral pooled fecal microbiotherapy after intensive chemotherapy: the phase Ib CIMON trial
Florent Malard, Sylvain Thepot, Thomas Cluzeau, et al.
Leukemia & Lymphoma
|
August 12, 2023
Use of tamibarotene, a potent and selective RARα agonist, in combination with azacitidine in patients with relapsed and refractory AML with <i>RARA</i> gene overexpression
Eytan M Stein, Stephane de Botton, Thomas Cluzeau, et al.
Oncotarget
|
October 22, 2015
IDH1/2 but not DNMT3A mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French Association
Houria Debarri, Delphine Lebon, Christophe Roumier, et al.
Leukemia Research
|
May 21, 2025
Treatment-free remission in chronic myeloid leukemia with rare ABL1 gene fusions: Real-life study from the French CML group Fi-LMC
Hyacinthe Johnson-Ansah, Aude Charbonnier, Gabriel Etienne, et al.
Leukemia
|
June 24, 2025
Comparison of induction with arsenic trioxide or chemotherapy in a real-world cohort of patients with high-risk acute promyelocytic leukemia
Delphine Lebon, Audrey Da Rocha, Bruno Cassinat, et al.
British Journal of Haematology
|
May 29, 2023
Combining thrombopoietin receptor agonists with immunosuppressive drugs in adult patients with multirefractory immune thrombocytopenia, an update on the French experience
Etienne Crickx, Mikael Ebbo, Etienne Rivière, et al.
European Journal of Haematology
|
May 15, 2025
Myeloid Neoplasms With Erythroid Predominance and Excess Blasts in Young Adults Exhibit Distinct Genetic Profiles
Laurène Fenwarth, Benjamin Podvin, Loïc Vasseur, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 47) with videos related to
Sort By:
Page
of 5
Cancers
|
May 5, 2021
The Impact of DNMT3A Status on NPM1 MRD Predictive Value and Survival in Elderly AML Patients Treated Intensively
Maël Heiblig, Nicolas Duployez, Alice Marceau, et al.
Haematologica
|
August 16, 2019
PIEZO1 activation delays erythroid differentiation of normal and hereditary xerocytosis-derived human progenitor cells
Alexis Caulier, Nicolas Jankovsky, Yohann Demont, et al.
Blood Advances
|
May 19, 2023
LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA study
Loïc Vasseur, Laurène Fenwarth, Jérôme Lambert, et al.
Blood Advances
|
April 8, 2025
Gut microbiota restoration with oral pooled fecal microbiotherapy after intensive chemotherapy: the phase Ib CIMON trial
Florent Malard, Sylvain Thepot, Thomas Cluzeau, et al.
Leukemia & Lymphoma
|
August 12, 2023
Use of tamibarotene, a potent and selective RARα agonist, in combination with azacitidine in patients with relapsed and refractory AML with <i>RARA</i> gene overexpression
Eytan M Stein, Stephane de Botton, Thomas Cluzeau, et al.
Oncotarget
|
October 22, 2015
IDH1/2 but not DNMT3A mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French Association
Houria Debarri, Delphine Lebon, Christophe Roumier, et al.
Leukemia Research
|
May 21, 2025
Treatment-free remission in chronic myeloid leukemia with rare ABL1 gene fusions: Real-life study from the French CML group Fi-LMC
Hyacinthe Johnson-Ansah, Aude Charbonnier, Gabriel Etienne, et al.
Leukemia
|
June 24, 2025
Comparison of induction with arsenic trioxide or chemotherapy in a real-world cohort of patients with high-risk acute promyelocytic leukemia
Delphine Lebon, Audrey Da Rocha, Bruno Cassinat, et al.
British Journal of Haematology
|
May 29, 2023
Combining thrombopoietin receptor agonists with immunosuppressive drugs in adult patients with multirefractory immune thrombocytopenia, an update on the French experience
Etienne Crickx, Mikael Ebbo, Etienne Rivière, et al.
European Journal of Haematology
|
May 15, 2025
Myeloid Neoplasms With Erythroid Predominance and Excess Blasts in Young Adults Exhibit Distinct Genetic Profiles
Laurène Fenwarth, Benjamin Podvin, Loïc Vasseur, et al.
Page
of 5